Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Medicine
  • Medicine News
  • Covid-19 patients with...

Covid-19 patients with existing Hemoglobinopathy may have more complications

Medical Dialogues Editorial TeamWritten by Medical Dialogues Editorial Team Published On 2021-12-30T09:00:02+05:30  |  Updated On 2021-12-30T09:00:20+05:30
Covid-19 patients with existing Hemoglobinopathy may have more complications

According to a new study done by Jun Xin Lee and colleagues, clinical presentation and lab results in individuals with hemoglobinopathy and those without were identical. Patients with hemoglobinopathy died at a higher rate than the general population, and those who have underlying cardiovascular or respiratory illnesses should be handled with extra vigilance. The findings of this study...

According to a new study done by Jun Xin Lee and colleagues, clinical presentation and lab results in individuals with hemoglobinopathy and those without were identical. Patients with hemoglobinopathy died at a higher rate than the general population, and those who have underlying cardiovascular or respiratory illnesses should be handled with extra vigilance.

The findings of this study were published in Frontiers of Medicine on 13th October, 2021.

Hemoglobinopathy is a chronic condition in and of itself. Patients with hemoglobinopathy are a distinct group with unique health requirements. Cardiopulmonary comorbidities that develop as a result of the illness are one of the leading causes of death and morbidity in this population. Concerns have been raised about whether this group of patients is more vulnerable to COVID-19 infection and a more severe course of disease due to their immunocompromised status and other comorbidities.

The purpose of this systematic review was to offer an overview of the clinical profile and outcome of COVID-19 infection in hemoglobinopathy patients. COVID-19 mortality rates and predictors were also discovered.

A systematic search was undertaken in five electronic databases (PubMed, Scopus, Web of Science, Embase, and WHO) in accordance with PRISMA principles. COVID-19 database) for publications published between December 1, 2019 and October 31, 2020. We considered all publications that had laboratory-confirmed COVID-19 patients with underlying hemoglobinopathy. The Joanna Briggs Institute (JBI) critical assessment checklists were used to assess methodological quality. This study comprised 31 papers with data on 246 people with hemoglobinopathy.

The key findings of this study are:

1. Clinical symptoms of COVID-19 infection in individuals with hemoglobinopathy were comparable to those seen in the general population.

2. Vaso-occlusive crises occurred in 55.6% of sickle cell disease patients who were infected with COVID-19.

3. The mortality rate from COVID-19 infection was 6.9% in individuals with hemoglobinopathy.

4. After controlling for age, gender, hemoglobinopathy type, and oxygen supplementation, respiratory and cardiovascular comorbidities were found to be significant predictors of death.

5. When compared to the general population, patients with hemoglobinopathy had a greater death risk from COVID-19 infection.

In conclusion, Clinicians who treat COVID-19 patients with underlying hemoglobinopathy should be extremely cautious, especially if other cardiovascular or respiratory comorbidities are present. More large-scale, long-term research is needed to assess the effect and long-term morbidity of COVID-19 infection in hemoglobinopathy patients.

Reference:

Lee JX, Chieng WK, Lau SCD, Tan CE. COVID-19 and hemoglobinopathies: a systematic review of clinical presentations, investigations, and outcomes. Front Med (Lausanne). 2021;8:757510. doi:10.3389/fmed.2021.757510

Frontiers of Medicine Covid-19 hemoglobinopathy 
Source : Frontiers of Medicine
Medical Dialogues Editorial Team
Medical Dialogues Editorial Team

    Medical Dialogues consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.

    Show Full Article
    Next Story
    Similar Posts
    NO DATA FOUND

    Editorial

    Journal Club Today

    Health News Today

    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok